Electrostatic complementarity of B-cell receptor CDR3s and TP53-mutant amino acids in breast cancer is associated with increased disease-free survival rates

Authors: Juan F. Arturo, Boris I. Chobrutskiy, Michelle Yeagley, Dhruv N. Patel, Shayan Falasiri, Jay S. Patel, George Blanck

Published: 2019-11-15

DOI: 10.1038/s41423-019-0328-8

Source: Full article


Abstract

No abstract found.